Rosuvastatin calcium and Atypical femur fracture - a phase IV clinical study of FDA data

Summary:

Atypical femur fracture is reported only by a few people who take Rosuvastatin Calcium.

The phase IV clinical study analyzes which people take Rosuvastatin calcium and have Atypical femur fracture. It is created by eHealthMe based on reports of 15,609 people who have side effects while taking Rosuvastatin calcium from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 27, 2023

15,609 people reported to have side effects when taking Rosuvastatin calcium.
Among them, 3 people (0.02%) have Atypical femur fracture.

What is Rosuvastatin calcium?

Rosuvastatin calcium has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 15,975 Rosuvastatin calcium users for its effectiveness, alternative drugs and more.

What is Atypical femur fracture?

Atypical femur fracture is found to be associated with 455 drugs and 179 conditions by eHealthMe.

Number of Rosuvastatin calcium and Atypical femur fracture reports submitted per year:

$Could Rosuvastatin calcium cause Atypical femur fracture?$

Time on Rosuvastatin calcium when people have Atypical femur fracture *:

Gender of people who have Atypical femur fracture when taking Rosuvastatin calcium *:

female: 100 %
male: 0.0 %

Age of people who have Atypical femur fracture when taking Rosuvastatin calcium *:

Common drugs people take besides Rosuvastatin calcium *:

Common side effects people have besides Atypical femur fracture *:

Fall: 3 people, 100.00%
Femur Fracture: 2 people, 66.67%
Weakness: 1 person, 33.33%
Pathological Fracture (broken bone caused by disease): 1 person, 33.33%
Pain: 1 person, 33.33%
Low Turnover Osteopathy (slow removal of old bone and its replacement by new bone): 1 person, 33.33%
Joint Pain: 1 person, 33.33%
Fracture Displacement: 1 person, 33.33%
Fracture Delayed Union (delayed cure of broken bone): 1 person, 33.33%
Chest Pain: 1 person, 33.33%

Common conditions people have *:

Osteoporosis (bones weak and more likely to break): 2 people, 66.67%
Muscle Spasms (muscle contraction): 1 person, 33.33%
Insomnia (sleeplessness): 1 person, 33.33%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 33.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Rosuvastatin calcium and have Atypical femur fracture?

Check whether Atypical femur fracture is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Common Rosuvastatin calcium side effects:

Drug ineffective: 2,037 reports
Fatigue (feeling of tiredness): 1,689 reports
Pain: 1,640 reports
High blood pressure: 1,517 reports
Breathing difficulty: 1,408 reports
Joint pain: 1,312 reports
Headache (pain in head): 1,241 reports
Cough: 1,228 reports

Browse all side effects of Rosuvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Atypical femur fracture treatments and more:

Atypical femur fracture (2,757 reports)

COVID vaccines that are related to Atypical femur fracture:

Common drugs associated with Atypical femur fracture:

All the drugs that are associated with Atypical femur fracture:

Atypical femur fracture (455 drugs)

Common conditions associated with Atypical femur fracture:

Osteoporosis: 1,130 reports
Osteoporosis post-menopausal: 245 reports

All the conditions that are associated with Atypical femur fracture:

Atypical femur fracture (179 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rosuvastatin calcium (the active ingredients of Rosuvastatin calcium) and Rosuvastatin calcium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.